Chapter 3. Osteoclast Biology and Bone Resorption

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation and function of Th17 T cells.

  2007cited by this paper
• M‐CSF, c‐Fms, and Signaling in Osteoclasts and their Precursors

  2006cited by this paper
• Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival

  2006cited by this paper
• MCP-1-induced Human Osteoclast-like Cells Are Tartrate-resistant Acid Phosphatase, NFATc1, and Calcitonin Receptor-positive but Require Receptor Activator of NFκB Ligand for Bone Resorption*

  2006cited by this paper
• Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche.

  2005cited by this paper
• Rho GTPases: biochemistry and biology.

  2005cited by this paper
• Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.

  2005cited by this paper
• Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines

  2005cited by this paper
• αvβ3 and macrophage colony‐stimulating factor: partners in osteoclast biology

  2005cited by this paper
• Regulation of Actin Ring Formation by Rho GTPases in Osteoclasts*

  2005cited by this paper
• Vav3 regulates osteoclast function and bone mass

  2005cited by this paper
• Osteoclast signalling pathways.

  2005cited by this paper
• Mechanisms of sex steroid effects on bone.

  2005cited by this paper
• Mechanistic insight into osteoclast differentiation in osteoimmunology

  2005cited by this paper
• Regulation of Osteoclast Apoptosis and Motility by Small GTPase Binding Protein Rac1

  2005cited by this paper
• Osteoporosis and integrins.

  2005cited by this paper
• Fos/AP‐1 proteins in bone and the immune system

  2005cited by this paper
• Role of oestrogen in the regulation of bone turnover at the menarche.

  2005cited by this paper
• MCP-1 Is Induced by Receptor Activator of Nuclear Factor-κB Ligand, Promotes Human Osteoclast Fusion, and Rescues Granulocyte Macrophage Colony-stimulating Factor Suppression of Osteoclast Formation*

  2005cited by this paper
• Immune Response: The Key to Bone Resorption in Periodontal Disease.

  2005cited by this paper
• Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1α) in human multiple myeloma

  2005cited by this paper
• The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function

  2005cited by this paper
• Endocytic trafficking in actively resorbing osteoclasts

  2004cited by this paper
• Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function.

  2004cited by this paper
• Perspectives on glucocorticoid-induced osteoporosis.

  2004cited by this paper
• Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

  2004cited by this paper
• Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models.

  2004cited by this paper
• CSF-1 regulation of the wandering macrophage: complexity in action.

  2004cited by this paper
• Osteoclast differentiation and activation

  2003cited by this paper
• Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.

  2003cited by this paper
• The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis

  2003cited by this paper
• Genetic regulation of osteoclast development and function

  2003cited by this paper
• RANKL and RANK as novel therapeutic targets for arthritis.

  2003cited by this paper
• Breast cancer metastasis to bone: it is not all about PTHrP.

  2003cited by this paper
• Membrane Recognition and Targeting by Lipid-Binding Domains

  2003cited by this paper
• Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

  2002cited by this paper
• Osteoprotegerin deficiency and juvenile Paget's disease.

  2002cited by this paper
• Function of prostanoid receptors: studies on knockout mice.

  2002cited by this paper
• Integrins: bidirectional, allosteric signaling machines.

  2002cited by this paper
• Manipulating the environment of cancer cells in bone: a novel therapeutic approach.

  2002cited by this paper
• Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption.

  2001cited by this paper
• The cell biology of osteoclast function.

  2000cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Removal of osteoclast bone resorption products by transcytosis.

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Long-term treatment of osteopetrosis with recombinant human interferon gamma.

  1995cited by this paper
• Molecular mechanisms of bone resorption

  1995cited by this paper

• No citing papers are available for this paper.